Results 91 to 100 of about 98,054 (191)

OMERACT Quality-adjusted Life-years (QALY) Working Group: Do Current QALY Measures Capture What Matters to Patients?

Journal of Rheumatology, 2017
L. Trenaman, A. Boonen, F. Guillemin, M. Hiligsmann, Alison M Hoens, C. Marra, W. Taylor, J. Barton, P. Tugwell, G. Wells, N. Bansback   +10 more
semanticscholar   +1 more source

Economic evaluation of direct oral anticoagulants (DOACs) for venous thromboembolism with different etiologies: a systematic review. [PDF]

Health Econ Rev
Karimi F, Rajaie S, Azari S, Abbaszadeh MS, Karimi Z.   +4 more
europepmc   +1 more source

Health outcomes in economic evaluation: the QALY and utilities.

British Medical Bulletin, 2010
S. J. Whitehead, Shehzad Ali
semanticscholar   +1 more source

Time to Treatment Discontinuation and Cost Effectiveness of Third-Line Therapies in Advanced Colorectal Cancer: Real-World Evidence from the NIH All of Us Research Program. [PDF]

Drugs Real World Outcomes
Kiel PJ, McGiffin MW, Skaar TC, Preston MA.   +3 more
europepmc   +1 more source

The limitations of QALY: a literature review

, 2016
D. Pettitt, S. Raza, B. Naughton, A. Roscoe, A. Ramakrishnan, A. Ali, Benjamin M. Davies, S. Dopson, G. Holländer, James A. Smith, D. Brindley   +10 more
semanticscholar   +1 more source

Cost-effectiveness of sugemalimab plus chemotherapy versus placebo plus chemotherapy as first-line treatment for advanced oesophageal squamous cell carcinoma in China. [PDF]

BMJ Open
Yan C, Li Z, Li J, Huang R, Li S, Diao R.   +5 more
europepmc   +1 more source

Cost-effectiveness of ramucirumab plus paclitaxel as maintenance therapy for patients with advanced HER2-negative gastric or gastroesophageal junction cancer. [PDF]

Front Oncol
Li D, Zhao X, Jia H, Cui R, Cao A, Huo L.   +5 more
europepmc   +1 more source

Economic evaluation of 22 HPV vaccination strategies to minimize the risk of penile, anal, and oropharyngeal cancers in Chinese males: A Markov model analysis. [PDF]

Hum Vaccin Immunother
Wang D, Luo W, Qin R, Xu G, Chai P, Liu B, Zhou L, Zhang X.   +7 more
europepmc   +1 more source

Cost-utility Analysis of R-CHOP vs CHOP in Patients with Non-Hodgkin's Lymphoma: A Systematic Review. [PDF]

Acta Med Philipp
Cadag CFT, Lorenzo AB, Mercado JMM, Ngo FLU.   +3 more
europepmc   +1 more source

Comparing WTP values of different types of QALY gain elicited from the general public.

Health Economics, 2015
M. Pennington, R. Baker, W. Brouwer, H. Mason, Dorte Gyrd - Hansen, A. Robinson, C. Donaldson   +6 more
semanticscholar   +1 more source